Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
77 studies found for:    anemia OR aplastic anemia OR iron-defiency OR sickle cell OR fanconi anemia OR pernicious anemia | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting The Role of Endothelin-1 in Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: Ambrisentan;   Drug: Placebo
22 Recruiting RBC Irradiation, Anemia and Gut Injury
Conditions: Anemia;   Necrotizing Enterocolitis
Intervention: Device: Near Infrared Spectroscopy
23 Recruiting Optimized Erythropoietin (EPO) Treatment
Condition: Neonatal Anemia
Interventions: Drug: Epoetin Alpha;   Drug: Biotinylated Red Blood Cells
24 Not yet recruiting Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Conditions: Anemia;   Myelodysplastic Syndrome
Interventions: Drug: Deferasirox;   Other: Laboratory Biomarker Analysis
25 Recruiting Screening for Subjects to Participate in Studies of Blood Disorders
Conditions: Bone Marrow Transplant;   Sickle Cell Disease;   G-CSF
Intervention:
26 Recruiting Safety Study of Cord Blood Units for Stem Cell Transplants
Conditions: Aplastic Anemia;   Leukemia;   Myelodysplastic Syndrome (MDS);   Lymphoma
Intervention: Procedure: Cord Blood Units
27 Not yet recruiting Omega-3 Fatty Acids in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: SCD-Omegatex™
28 Not yet recruiting Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Condition: Severe Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
29 Recruiting Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial
Condition: Anemia
Interventions: Procedure: Drawing admission labs from cord blood;   Procedure: Drawing admission labs from infant blood
30 Recruiting Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
Conditions: Hemoglobinopathies;   Hemolysis;   Iron Deficiency and Overload;   Anemias
Intervention:
31 Recruiting Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders
Conditions: Immunodeficiency Syndrome;   Non-Cancer Diagnosis;   Severe Aplastic Anemia
Interventions: Procedure: Allogeneic Bone Marrow Transplantation;   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mycophenolate Mofetil;   Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Sirolimus;   Drug: Tacrolimus;   Radiation: Total-Body Irradiation
32 Recruiting The Role and Effect of Anemia in Children With Pneumonia
Conditions: Anemia;   Pneumonia
Intervention: Other: none - observational only
33 Recruiting Developing the Family Map: Looking at Communal Coping
Conditions: Diabetes;   Cancer;   Cardiovascular Disease;   Sickle Cell Disease
Intervention:
34 Not yet recruiting Screening for Alpha Thalassemia in Healthy Volunteers
Condition: Alpha Thalassemia
Intervention:
35 Recruiting Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Condition: Healthy
Intervention:
36 Recruiting Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS);   Hematologic Neoplasms;   Hematologic Diseases;   Severe Aplastic Anemia
Intervention: Procedure: Cord Blood Transplant
37 Recruiting BioRBC Survival in Adults With Prior Antibody Response to BioRBCs
Condition: Anemia
Intervention: Drug: biotin labelled RBCs
38 Recruiting Radiation Therapy and the Natural History of Childhood Cancers
Conditions: Cancer;   Childhood Malignancy
Intervention:
39 Recruiting Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Condition: Sickle Cell Disease
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: r-ATG;   Procedure: Bone Marrow Transplant;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Standard of Care
40 Recruiting The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Condition: Glanzmann Thrombasthenia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.